MedTrace Logo

Association of Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon

NCT05685875 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-01-17

No results posted yet for this study

Summary

The aim of this study is to investigate if diabetes, obesity and metabolic syndrome affects disease presentation and severity of malaria in adults in a hospital setting in Cameroon.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity
  • Metabolic Syndrome
  • Severe Malaria
  • Malaria,Falciparum

Interventions

OTHER

diabetes

Diabetes and metabolic syndrome defined using criteria by IDF. Obesity defined as BMI\>=30

Sponsors & Collaborators

Principal Investigators

  • Anna Färnert, Prof · Karolinska Institutet

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-07
Primary Completion
2023-05-31
Completion
2023-06-30

Countries

  • Cameroon

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05685875 on ClinicalTrials.gov